United States Food and Drug Administration
PulseAugur coverage of United States Food and Drug Administration — every cluster mentioning United States Food and Drug Administration across labs, papers, and developer communities, ranked by signal.
- parent of Center for Drug Evaluation and Research 100%
- subsidiary of United States Department of Health and Human Services 100%
- employed by Marty Makary 95%
- employed by Kyle Diamantas 90%
- other Supreme Court of the United States 60%
- affiliated with Biden Administration 60%
- affiliated with Joe Biden Administration cabinet 60%
- other Marty Makary 60%
- 2026-05-23 regulatory The FDA published new guidelines allowing certain e-cigarettes and nicotine pouches onto the market without full regulatory vetting. 来源
- 2026-05-19 product_launch The FDA approved the first gene therapy for deafness. 来源
- 2026-05-18 hiring Marty Makary has departed as FDA commissioner, leading to a change in leadership at the agency. 来源
- 2026-05-16 hiring Dr. Tracy Beth Hoeg was removed from her role as acting director of the FDA's drug program and replaced by Dr. Mike Davis. 来源
- 2026-05-15 regulatory The FDA is preparing to issue alerts regarding AI hallucinations in healthcare by 2026. 来源
- 2026-05-15 regulatory The FDA eased restrictions on certain vaping products and reconsidered a ban on minors using tanning beds. 来源
- 2026-05-12 hiring US Food and Drug Commissioner Marty Makary resigned, with Kyle Diamantas stepping in as acting head. 来源
- 2026-05-12 hiring FDA Commissioner Marty Makary is stepping down after a turbulent 13-month term. 来源
- 2026-05-12 hiring FDA Commissioner Marty Makary resigned after a tumultuous 13-month tenure. 来源
14 天有情绪数据
-
AI enables DNA programming, with data loops as key advantage
AI is enabling the programming of DNA, moving beyond text-based models like those used for ChatGPT. Researchers are treating the genome as a language, using transformer architectures to predict and autocomplete genetic …
-
Mingpai Industrial halts Caibai stake reduction; Rejebio drug trial expands
Zhejiang Mingpai Industrial Co., Ltd. has decided to terminate its plan to reduce its stake in Caibai Co., Ltd., having not sold any shares. Concurrently, Shun Jing Pharmaceutical, a subsidiary of Rejebio, has received …
-
热景生物 subsidiary drug SGC001 gains approval for new pancreatitis trial
热景生物's subsidiary, Shun Jing Medicine, has received approval for its innovative drug SGC001 injection to undergo clinical trials for an additional indication: severe acute pancreatitis. This drug has already received cl…
-
Agentic AI promises integrated healthcare solutions beyond traditional systems
Agentic AI represents a significant advancement over traditional AI in the healthcare sector, offering a more integrated and proactive approach to patient care and administrative tasks. Unlike specialized traditional AI…
-
FDA officials blindsided by new e-cig and nicotine pouch market rules
Senior officials at the FDA's tobacco center were reportedly blindsided by new guidelines that permit certain electronic cigarettes and nicotine pouches to enter the U.S. market without full regulatory review. These gui…
-
Apple Watch, AirPods gain new health features in India
Apple is expanding health features to India, making sleep apnoea notifications available on Apple Watch and a hearing test feature accessible via AirPods Pro 2 and 3. The sleep apnoea feature, previously FDA-cleared, de…
-
Enhanced Games encourage drug use to break world records
The inaugural Enhanced Games are set to take place in Las Vegas, featuring 42 athletes who are encouraged to use performance-enhancing drugs under medical supervision. The competition aims to push the boundaries of huma…
-
Allergy immunotherapy offers a path to reduced seasonal reactions
Seasonal allergies can be managed and potentially overcome through immunotherapy, a process involving exposure to small, increasing amounts of allergens. This treatment, available as injections (SCIT) or under-the-tongu…
-
US overdose deaths drop 27% in 2024, but addiction crisis persists
Overdose deaths in the United States saw a significant decrease of nearly 27% in 2024, with synthetic opioid fatalities dropping by 37%. Despite this historic decline, public health experts remain cautiously optimistic,…
-
中信证券：FDA政策转向利好电子烟头部企业
中信证券发布研报指出，美国FDA近期出台了两项关键政策，首次授权水果口味电子烟产品通过PMTA上市，并发布了关于新型烟草产品执法的优先事项。这些政策可能允许合规的调味电子烟和口含烟产品提前进入市场。结合中国取消电子烟出口退税和实施出口配额制，美国市场供应端将加速整合，市场份额有望向头部企业集中，预示着合规市场将迎来修复性增长。
-
Cookware giants sue Caraway over 'toxic' non-stick claims
Two major cookware manufacturers, Groupe SEB and Meyer Corporation, have filed a lawsuit against startup Caraway Home for allegedly false advertising. The plaintiffs accuse Caraway of falsely marketing its ceramic cookw…
-
FDA approves first gene therapy for genetic deafness
The FDA has approved the first gene therapy designed to treat deafness caused by a specific genetic mutation. This groundbreaking treatment targets the OTOF gene, which is crucial for transmitting sound signals from the…
-
FDA leadership change impacts drug safety, vaccine trust
The U.S. Food and Drug Administration (FDA) is undergoing a leadership change, with Marty Makary departing as commissioner. The agency's new acting leader will influence critical decisions regarding drug safety, vaccine…
-
FDA official Tracy Beth Hoeg removed from drug program leadership
Dr. Tracy Beth Hoeg has been removed from her position as acting director of the Food and Drug Administration's drug program. Her departure follows a series of leadership changes at the agency, including the resignation…
-
AI agents accelerate software development but require human oversight
Developers are increasingly using AI agents to accelerate software development, with one user reporting a 55% cost and 40-50% time saving on an MVP build by employing specialized agents for tasks like architecture, codi…
-
FDA to Alert on AI Hallucinations in Healthcare by 2026
The FDA is preparing to issue alerts in 2026 regarding the significant patient safety risks posed by AI hallucinations in healthcare. These systems can generate convincing but false information, creating a critical reli…
-
FDA eases vape, tanning bed rules amid MAHA administration shift
The FDA has eased restrictions on certain vaping products and is reconsidering a ban on minors using tanning beds, signaling a shift in priorities under the MAHA administration. These changes risk undermining efforts to…
-
Trump Admin Vaping Policy Shift Sparks HHS Resignations
The second Trump administration is reportedly pivoting its policy on vaping, leading to resignations within the Department of Health and Human Services. Rich Danker, chief spokesperson for HHS Secretary Robert F. Kenned…
-
New TMLE methods boost subgroup analysis in clinical trials
Researchers have developed new statistical methods, specifically two Targeted Maximum Likelihood Estimators (TMLEs), to improve the power of subgroup analyses in randomized controlled trials. These methods, TMLE-PR and …
-
Food dye bans offer illusion of health, not real dietary change
Removing artificial food dyes will not significantly improve American diets, despite widespread public support for such changes. Consumers often express a desire for cleaner ingredients but continue to purchase products…